Vision
Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system.
Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood.
News
01 Apr 2025
New publication by University Hospital of Wales demonstrates monitoring of patients under anti-CD20 therapies using home sampling in combination with dried-blood spot based epigenetic quantification of B cells.
For a Spanish version of this video please click here!